✦ LIBER ✦

Treatment of psoriasis with the chimeric monoclonal antibody against tumor necrosis factor α, infliximab

✍ Scribed by Rudolf E. Schopf; Holger Aust; Jürgen Knop

Book ID: 117845370
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 522 KB
Volume: 46
Category: Article
ISSN: 1097-6787
DOI: 10.1067/mjd.2002.120472

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of rheumatoid arthritis with c

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

✍ Michael J. Elliott; Ravinder N. Maini; Marc Feldmann; Alice Long-Fox; Peter Char 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 1018 KB

Successful treatment of active ankylosin

Successful treatment of active ankylosing spondylitis with the anti–tumor necrosis factor α monoclonal antibody infliximab

✍ Jan Brandt; Hildrun Haibel; Daniel Cornely; Werner Golder; José Gonzalez; Jaquel 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 584 KB

Psoriasis and its treatment with inflixi

Psoriasis and its treatment with infliximab-mediated tumor necrosis factor α blockade

✍ Winterfield, Laura; Menter, Alan 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 222 KB

Pharmacodynamic and pharmacokinetic resp

Pharmacodynamic and pharmacokinetic response to anti-tumor necrosis factor-α monoclonal antibody (infliximab) treatment of moderate to severe psoriasis vulgaris

✍ Alice B. Gottlieb; Salman Masuda; Rallapalli Ramamurthi; Ahsan Abdulghani; Pat R 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 255 KB

Treatment with anti-tumor necrosis facto

Treatment with anti-tumor necrosis factor α (TNF-α) monoclonal antibody dramatically decreases the clinical activity of psoriasis lesions

✍ Charles J. Oh; Kiron M. Das; Alice B. Gottlieb 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Randomized double-blind comparison of ch

Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor α (infliximab) versus placebo in active spondylarthropathy

✍ Filip Van den Bosch; Elli Kruithof; Dominique Baeten; Annemie Herssens; Filip de 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

## Abstract ## Objective To confirm in a placebo‐controlled trial the safety and efficacy profile of infliximab in short‐term treatment of patients with active spondylarthropathy (SpA). ## Methods Forty patients with active SpA were randomly assigned to receive an intravenous loading dose (weeks